#Denmark #ophthalmology #LYNX #Norlase #Ballerup

Norlase LYNX™: A Breakthrough in Ophthalmology

Norlase, a leader in ophthalmic laser technology, recently announced a groundbreaking innovation: the LYNX™, the world's first and only laser indirect ophthalmoscope equipped with pattern-scanning capabilities. This device has successfully acquired FDA 510(k) approval and CE marking, marking a significant milestone in the field of eye care.

Unveiling the LYNX™

The LYNX™ is designed for versatility and convenience, embodying sleek portability and user-friendly features. It allows ophthalmic surgeons to perform procedures nearly anywhere, eliminating the traditional limitations tied to laser equipment. This device couples an integrated laser and pattern-scanning module within a single ergonomically designed unit. Surgeons no longer require an external laser beam source, enhancing treatment flexibility and efficiency.

Oliver Hvidt, CEO and co-founder of Norlase, commented, "Time is of the essence for ophthalmologists today. The demand for an advanced laser indirect ophthalmoscope has been present since the inception of pattern scanning lasers over 15 years ago. With the introduction of LYNX™, we have revolutionized the way procedures are performed. Quick treatments with the LIO translate to reduced ergonomic stress, improved patient interaction, and timely medical appointments. I take immense pride in our team and appreciate the ophthalmologists who collaborated with us in developing this device."

Features of the LYNX™

The features of the LYNX™ are designed to optimize performance:

• - Integrated System: Combines the laser, scanner, and delivery system into an ultralight, portable unit.
• - Battery-Powered: Offers portability and flexibility, enabling surgeons to operate in various locations.
• - Wide Range of Patterns: Includes grid patterns from 2x2 to 5x5, triple arcs, and circles for diverse procedural needs.
• - SimplyCLEAR Filters: Provide enhanced visualization for improved patient outcomes.
• - Multilingual Voice Control: Facilitates seamless adjustment of patterns and parameters, catering to a global user base.

Positive Reception from Users

Early adopters of the LYNX™ have expressed their enthusiasm for this innovative tool. Dr. Daniel Diaz from Retina Consultants of Miami stated, "This cutting-edge device marries the speed and efficiency of pattern scanning laser technology with unparalleled user comfort and portability, setting a new benchmark for indirect laser procedures. The mobility and robust pattern options significantly reduce procedure time while enhancing the quality of retinal surgeries."

The LYNX™ represents Norlase's fourth product launch in just five years, reinforcing its commitment to innovation in ophthalmic laser solutions. Following the success of previous devices like LEAF, LION, and ECHO, the LYNX™ aims to make state-of-the-art laser technology more accessible to eye care professionals worldwide.

About Norlase

Founded in Denmark, Norlase is dedicated to developing next-generation laser solutions for treating retinal diseases and glaucoma. The company is comprised of world-class experts in ophthalmology, laser technology, and medical device development. Norlase's mission is to enhance the efficiency of medical practice and improve patient care and doctor comfort across the globe.

For more information on the LYNX™ and other Norlase products, visit norlase.com.